Andrea Lancia
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Allergic Respiratory Diseases in the Climate Change Context: Aerobiological Tools and Projections as Preventive Actions for Pollen-Induced Allergies.
Journal: Medical sciences (Basel, Switzerland)
Published: July 02, 2026
Novel biomarkers driving treatment selection in metastatic castration-sensitive prostate cancer: fundamentals of personalized clinical decision making.
Journal: Expert review of clinical pharmacology
Published: May 19, 2026
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial.
Journal: BJU international
Published: December 15, 2025
Recent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 08, 2025
Ablative radiotherapy for polymetastatic disease: a new kid on the block.
Journal: Expert review of anticancer therapy
Published: August 01, 2025
A non-small cell lung cancer fragile elderly patient treated with immunotherapy and non-ablative radiation therapy: a case report of a winning combination.
Journal: Frontiers in oncology
Published: June 06, 2025
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer.
Journal: Expert review of anticancer therapy
Published: May 21, 2025
Current Treatment Paradigms for Advanced Melanoma with Brain Metastases.
Journal: International journal of molecular sciences
Published: February 15, 2025
Combining Radiation Therapy With Immune Checkpoint Inhibitors for the Management of Muscle-Invasive Bladder Cancer: A Comprehensive Systematic Review From the Y-ECI ROSC EORTC Group.
Journal: Practical radiation oncology
Published: January 15, 2025
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).
Journal: Prostate cancer and prostatic diseases
Published: November 28, 2024
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study.
Journal: Prostate cancer and prostatic diseases
Published: November 12, 2024
Novel androgen receptor inhibitors in prostate cancer: What do we know so far?
Journal: Critical reviews in oncology/hematology
Published: October 20, 2024
Last Updated: 09/26/2026